Acquisition of Yuan Ye Biotech drives earnings growth. Shanghai Aladdin Biochemical Technology Co., Ltd.: All types of products have expansion plans. | Directly focusing on the earnings conference.

① By acquiring Yuan Ye Biotechnology, shanghai aladdin biochemical technology co.,ltd achieved high revenue growth in the first half of the year, with the net income attributable to the parent company increasing by 52.91% compared to the previous quarter. ② shanghai aladdin biochemical technology co.,ltd stated that with the resumption of normal teaching and research activities, the proportion of university customers has increased. In addition, with the expansion of universities in recent years and the increase in the number of postgraduates, the demand from universities is also rising. In the future, the company has expansion plans in various product categories.

cls.cnOct 14 02:59 ET

hunan sokan new materials plans to establish 2 new subsidiaries in the usa to further expand its automotive coating business.

①Regarding the layout of the automotive coating materials business, Hunan Sokan New Materials stated that the company has achieved a layout of "from interior to exterior" and "from small parts to large parts" starting from the auto parts coating market; ②In recent years, Hunan Sokan New Materials has been increasing its application and promotion efforts in the passenger autos market while developing the main business of high-end consumer electronics.

cls.cnSep 29 21:04 ET

Huawei's foldable phone pre-order has exceeded 3 million, and the industry has entered a period of stable growth.

Huawei Mate X Foldable Phone, which was available for pre-order on Huawei Store starting from September 7th, 12:08, has already received over 3 million reservations, reaching 3.137 million people. According to Debang Securities, mainstream smart phone manufacturers have largely completed the layout and iteration of their foldable screen product lines, and the foldable screen phone industry is gradually entering a stable growth period.

cls.cnSep 9 19:37 ET

Shandong Dongyue Organosilicon Materials' performance has grown against the trend. Will it see improved profits in the second half of the year? | Interpretations.

①In the first half of the year, Shandong Dongyue Organosilicon Materials achieved a revenue of 2.737 billion yuan, a year-on-year growth of 10.21%; net income attributable to shareholders was 65.2173 million yuan, a year-on-year growth of 134.05%; ②Since the beginning of this year, the organosilicon industry has continued to slump, with average prices in the first half of the year falling by about 8% compared to the same period last year. ③Organosilicon is about to enter the traditional peak demand season, coupled with the good overseas demand this year, the profitability of organosilicon companies may improve.

cls.cnAug 28 11:04 ET

Weak expansion of sales channels? Leading synthetic biology company Huaheng Biological's net profit fell more than 20% in the first half of the year.

Due to increased competition and rising costs, Huaheng Biotech's net income for the first half of the year fell by 21.72%. It is stated that the sales channels for the core product L-Xeonine need to be further expanded, and market share needs to be increased. The registered and effective issuance plan of Huaheng Biotech has been registered and effective, but it is stated that if the project cannot generate benefits as expected or the actual income is lower than expected, there may be a risk of reduced profitability.

cls.cnAug 27 09:38 ET

The overall weakness of fluorine chemical industry is revealed despite the soaring refrigerant prices. Zhejiang Juhua's Q2 net profit is lower than the peak in the same period of 2022 | Interpretations

① In Q2, zhejiang juhua had a net profit attributable to shareholders of 0.524 billion yuan, which was lower than the same period of 2022; ② The net profit attributable to shareholders in H1 increased by 70.31% year on year, and there is great pressure for profit growth in H2; ③ The refrigerant is outstanding, while other fluorine chemical products are dragging down the performance; ④ The company's diversified layout does not have an advantage in the current stage of the industry.

cls.cnAug 22 11:59 ET